Bill Text: NY S06542 | 2023-2024 | General Assembly | Introduced
Bill Title: Removes limitations on newborn screening for glucose-6-phosphate dehydrogenase deficiency.
Spectrum: Partisan Bill (Democrat 2-0)
Status: (Vetoed) 2023-12-22 - VETOED MEMO.143 [S06542 Detail]
Download: New_York-2023-S06542-Introduced.html
STATE OF NEW YORK ________________________________________________________________________ 6542 2023-2024 Regular Sessions IN SENATE April 26, 2023 ___________ Introduced by Sen. RIVERA -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to newborn screening for glucose-6-phosphate dehydrogenase deficiency The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Paragraph (j) of subdivision 1 of section 2500-a of the 2 public health law, as amended by chapter 70 of the laws of 2022, is 3 amended to read as follows: 4 (j) Glucose-6-phosphate dehydrogenase deficiency [using a quantitative5enzymatic test or other diagnostic test in cases where: the newborn6infant presents with hemolytic anemia, hemolytic jaundice, or early-on-7set increasing neonatal jaundice, that is, jaundice (bilirubin level8greater than fortieth percentile for age in hours) persisting beyond the9day of birth through the week after birth; the newborn infant has been10admitted to the hospital for jaundice following birth; or the biological11parent of the newborn infant indicates a family, racial, or ethnic risk12of glucose-6-phosphate dehydrogenase deficiency, including having13significant African, Asian, Mediterranean, or Middle Eastern ancestry]. 14 § 2. This act shall take effect immediately. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD10869-02-3